Inclinix, a Wilmington-based enrollment contract research organization has closed $10 million in expansion funding from Frontier Capital, a Charlotte private equity firm providing growth equity to business services companies.
Inclinix accelerates the clinical trials of new drugs by delivering qualified doctors and patients for enrollment. The company said it will use the investment to fund further enhancement of its proprietary enrollment processes and technologies. Inclinix will also add sales, marketing, and service delivery resources and expand its corporate facilities.
